Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Infect Genet Evol. 2014 Dec 23;30:147–158. doi: 10.1016/j.meegid.2014.12.021

Table 3.

Representation of maternal HLA-G genotypes, N (%)

HLA-G
Genotypes* 		NT
(n=14
4)		 IP-
TR
(n=2
9)		 IU-
TR
(n=19)		 IU-
TR
(n=4
3)		 IP-TR vs. NT IU-TR vs. NT IU2-TR vs. NT
OR (95%
CI)		 P OR (95%
CI)		 P OR (95%
CI)		 P
 G*01:01:01/G*01
:01:01 		17
(11.81
)		 3
(10.3
4)		 5
(26.32
)		 5
(11.6
3)		 0.86 (0.23-
3.16)		 1.00
0		 2.66 (0.85-
8.34)		 0.14
3		 0.98 (0.34-
2.84)		 1.00
0
 G*01:01:01/G*01
:01:02 		15
(11.81
)		 4
(13.7
9)		 3(15.7
9)		 4
(9.30
)		 1.37 (0.42-
4.49)		 0.74
4		 1.61 (0.42-
6.18)		 0.69
8		 0.88 (0.27-
2.81)		 1.00
0
 G*01:01:01/G*01
:01:09 		4
(2.78)		 0
(0.00
)		 1
(5.26)		 1
(2.33
)		 - 0.60
8		 1.94 (0.21-
18.3)		 1.00
0		 0.83 (0.09-
7.65)		 1.00
0
 G*01:01:01/G*01
:03:01 		4
(2.78)		 0
(0.00
)		 1
(5.26)		 2
(4.65
)		 - 0.60
8		 1.94 (0.21-
18.3)		 1.00
0		 1.71 (0.30-
9.66)		 0.62
2
 G*01:01:01/G*01
:04:01 		3
(2.08)		 2
(6.90
)		 0
(0.00)		 0
(0.00
)		 3.48 (0.56-
21.8)		 0.19
6		 - 1.00
0		 - 0.58
7
 G*01:01:01/G*01
:04:04 		17
(11.81
)		 4
(13.7
9)		 0
(0.00)		 6
(13.9
5)		 1.19 (0.37-
3.85)		 0.75
8		 - 0.22
4		 1.21 (0.44-
3.29)		 0.79
2
 G*01:01:01/G*01
:05N 		7
(4.86)		 1
(3.45 )		 0
(0.00)		 0 (0.00
)		 0.70 (0.08-
5.91)		 1.00
0		 - 0.60
2		 - 0.20
5
 G*01:01:02/G*01
:01:02 		6
(4.17)		 2
(6.90
)		 3
(15.79
)		 4
(9.30
)		 1.70 (0.33-
8.89)		 0.62
3		 4.31 (0.98-
18.9)		 0.07
2 		2.35 (0.63-
8.77)		 0.24
2
 G*01:01:02/G*01
:01:08 		3
(2.08)		 1
(3.45
)		 0
(0.00)		 1
(2.33
)		 1.67 (0.17-
16.7)		 1.00
0		 - 1.00
0		 1.11 (0.11-
11.0)		 1.00
0
 G*01:01:02/G*01
:01:19 		4
(2.78)		 0
(0.00
)		 0
(0.00)		 0
(0.00
)		 - 0.60
8		 - 1.00
0		 - 0.57
5
 G*01:01:02/G*01
:03:01 		4
(2.78)		 0
(0.00
)		 2
(10.53
)		 5
(11.6
3)		 - 0.60
8		 4.11 (0.70-
24.1)		 0.14
5		 4.61 (1.17-
17.9)		 0.03
1
 G*01:01:02/G*01
:04:01 		3
(2.08)		 0
(0.00
)		 0
(0.00)		 1
(2.33
)		 - 1.00
0		 - 1.00
0		 1.11 (0.11-
11.0)		 1.00
0
 G*01:01:02/G*01
:04:04 		10
(6.94)		 2
(6.90
)		 2
(10.53
)		 4 (9.30
)		 1.00 (0.21-
4.78)		 1.00
0		 1.57 (0.32-
7.81)		 0.63
4		 1.37 (0.41-
4.62)		 0.74
1
 G*01:01:02/G*01
:05N 		6
(4.17)		 0
(0.00
)		 0
(0.00)		 2
(4.65
)		 - 0.38
7		 - 0.61
5		 1.12 (0.22-
5.77)		 1.00
0
 G*01:01:08/G*01
:04:04 		3
(2.08)		 0
(0.00
)		 1
(5.26)		 1
(2.33
)		 - 1.00
0		 2.61 (0.26-
26.5)		 0.39
4		 1.11 (0.11-
11.0)		 1.00
0
 G*01:01:09/G*01
:05N 		3
(2.08)		 0 (0.0
0)		 0
(0.00)		 0 (0.00
)		 - 1.00
0		 - 1.00
0		 - 0.58
7
 G*01:03:01/G*01
:04:04 		3
(2.08)		 1
(3.45
)		 0
(0.00)		 0 (0.00
)		 1.67 (0.17-
16.7)		 1.00
0		 - 1.00
0		 - 0.58
7
 G*01:03:01/G*01
:05N 		4
(2.78)		 0
(0.00
)		 0
(0.00)		 0
(0.00
)		 - 0.60
8		 - 1.00
0		 - 0.57
5
 G*01:04:04/G*01
:04:04 		6
(4.17)		 0
(0.00
)		 0
(0.00)		 0
(0.00
)		 - 0.38
7		 - 0.61
5		 - 0.33
9
 G*01:04:04/G*01
:05N 		6
(4.17)		 1
(3.45
)		 0
(0.00)		 2
(4.65
)		 0.82 (0.09-
7.09)		 1.00
0		 - 0.61
5		 1.12 (0.22-
5.77)		 1.00
0
*

indicates HLA-G genotype frequencies > 2% in the NT group. NT: HIV-1 nontransmitting mother; IP-TR: intrapartum HIV-1 transmitting mother; IU-TR: in utero HIV-1 transmitting mother; IU2-TR: enriched group of presumed in utero transmitting mothers. Highlighted and bold P values indicate significant differences (P<0.05) and bold P values indicate trends (P<0.090).